• Braunol Povidone Iodine Antiseptic Solution for Skin Mucosa and Wounds
1 1

B. Braun

Braunol Povidone Iodine Antiseptic Solution for Skin Mucosa and Wounds

Braunol Povidone Iodine Antiseptic Solution for Skin Mucosa and Wounds

$5.70 SGD
$0.00 SGD $5.70 SGD
促销 售罄
结账时计算的运费。
Clinical Summary: Braunol (B. Braun, povidone-iodine 7.5% w/w aqueous solution, equivalent to 0.75% available iodine) is a broad-spectrum antiseptic for intact and damaged skin, mucous membranes, and wounds, with documented bactericidal, fungicidal, mycobactericidal, virucidal, and protozoal activity. Its onset of action is approximately 15–30 seconds with sustained brown staining indicating active drug presence on the skin. Indicated for surgical site preparation, mucous membrane antisepsis, and wound antisepsis. CE marked under EU MDR 2017/745; manufactured under ISO 13485; HSA Singapore registered.

Product Overview

Braunol is an aqueous antiseptic solution containing 7.5% povidone-iodine (PVP-I) corresponding to approximately 0.75% available iodine. It is supplied ready-to-use and may also be diluted with sterile water or saline for mucous membrane indications. Iodine is released slowly from the polyvinylpyrrolidone (povidone) carrier complex on contact with skin or wound tissue, providing rapid microbicidal activity with reduced cytotoxicity compared with aqueous iodine tincture, and lower allergenicity than chlorhexidine in iodine-tolerant patients.

Braunol is the German B. Braun reference product widely used in European operating theatres for skin disinfection prior to surgical incision, regional and central venous catheter insertion, mucosal antisepsis prior to oral, vaginal, urological, and ENT procedures, and antiseptic irrigation of acute and chronic wounds (per WHO Guidelines for Safe Surgery 2009 and recent EWMA position documents on antiseptic stewardship).

Specifications

Manufacturer B. Braun Melsungen AG (Germany)
Active Ingredient Povidone-iodine 7.5% w/w (approximately 0.75% available iodine)
Excipients Glycerol, disodium hydrogen phosphate dihydrate, citric acid monohydrate, sodium hydroxide, nonoxinol, purified water
Appearance Dark red-brown aqueous solution
pH Approximately 1.5 to 6.5 (formulation dependent)
Onset of Action ~15 to 30 seconds (bactericidal); 1 minute (virucidal/fungicidal per EN 13727, EN 14476)
Spectrum Bactericidal (incl. MRSA, VRE), fungicidal (Candida), mycobactericidal, virucidal (incl. HBV, HCV, HIV, SARS-CoV-2), protozoal
Indications Skin antisepsis, surgical site preparation, mucous membrane antisepsis, wound antisepsis
Contraindications Iodine hypersensitivity, hyperthyroidism, dermatitis herpetiformis Duhring; caution in neonates, pregnancy, lactation, large surface burns, lithium therapy, thyroid scintigraphy
Regulatory CE marked under EU MDR 2017/745; ISO 13485 manufactured; HSA Singapore registered medical product; conforms to EN 1500, EN 13727, EN 13624, EN 14476 efficacy standards
Packaging 30 ml, 100 ml, 250 ml, 500 ml, 1000 ml bottles (variant dependent)
Shelf Life 3 years unopened; use within 24 months after first opening
Storage Store below 25 degrees Celsius, protected from light, do not freeze

Clinical Indications

  • Pre-operative skin antisepsis at surgical site (WHO Guidelines for Safe Surgery 2009; CDC/HICPAC SSI prevention)
  • Antisepsis prior to central venous, peripheral, and arterial catheter insertion (CDC HICPAC catheter-related infection prevention; alternative to chlorhexidine in chlorhexidine-sensitive patients)
  • Mucous membrane antisepsis for oral, vaginal, urological, ENT, and ophthalmic preparation procedures (diluted as per IFU)
  • Acute traumatic wound and burn wound cleansing where iodophor antisepsis is preferred
  • Chronic wound antisepsis under EWMA antiseptic stewardship principles, time-limited courses with clinical reassessment
  • Pre-injection skin antisepsis where alcohol or chlorhexidine is contraindicated

Frequently Asked Questions

Q: What is the difference between Braunol 7.5% and an alcohol-based PVP-I (e.g. Betadine alcoholic solution)?
A: Braunol is an aqueous PVP-I solution suitable for skin, mucous membranes, and open wounds. Alcoholic PVP-I solutions provide faster onset and longer residual activity for intact-skin surgical-site antisepsis but are contraindicated on mucosa, open wounds, and electrocautery sites due to flammability and tissue irritation.

Q: Can Braunol be used on chronic wounds long term?
A: Per EWMA antiseptic stewardship guidance and Cochrane evidence reviews, antiseptic exposure on chronic wounds should be time-limited (typically 1–2 weeks), with clinical reassessment to avoid cytotoxicity and to limit selection pressure on local microflora. Braunol is appropriate for short antiseptic courses where biofilm or bioburden management is required.

Q: Does Braunol interfere with thyroid function?
A: Repeated, large-area, or prolonged use can transiently affect thyroid function due to systemic iodine absorption. Braunol is contraindicated in manifest hyperthyroidism and used with caution in neonates, pregnancy, lactation, and patients on lithium or scheduled thyroid scintigraphy. Thyroid function monitoring is appropriate after extensive paediatric burn antisepsis.

Q: Is Braunol the same as Betadine in Singapore practice?
A: Both are povidone-iodine 7.5–10% antiseptics. Braunol is the B. Braun German PVP-I formulation, registered with HSA Singapore, and frequently chosen by Singapore restructured hospitals and surgical day centres for its consistent batch quality and EN-tested efficacy data. Betadine is the Mundipharma brand. Substitution between brands is acceptable for most antiseptic indications.

Q: Is HSA registration required for clinical purchase in Singapore?
A: Braunol is HSA-registered and routinely procured by Singapore restructured hospitals, polyclinics, surgical centres, day procedure clinics, and home-care providers. EMIS+ supplies the genuine B. Braun product with full lot traceability for institutional procurement and B2B clinic accounts.

查看完整详细信息